Category: Uncategorized
-

Nvidia stock drops 4% after-hours amid CEO Jensen Huang affair reports
Nvidia experienced a 4% decline in its stock price after-hours, reportedly triggered by news of a second affair involving its CEO, Jensen Huang. The reports surfaced from social media sources, raising potential concerns among investors about the company’s leadership stability. Despite the negative sentiment, Nvidia’s board has stated that it found no evidence to suggest…
-

Nvidia Stock Tumbles As CEO Jensen Huang Had Second Affair, NYT Reports. N
Nvidia stock slid in extended trading on a report that embattled CEO Jensen Huang had a second affair, along with another report that the board is preparing to oust the chip-giant’s founder. The alleged relationship was with Kimberly Powell, vice president of healthcare at Nvidia (NVDA), according to the New York Times. Minutes later, the…
-
Individual Stock Swing Trading Part 3
Individual Stock Swing Trading | 3 Ways to Control Your Psychology To make a profit in swing trading, it is important not only to select stocks and analyze charts, but also to control your own emotions. No matter how excellent your analysis is, if you are swayed by fear or greed, you will not be…
-
NASDAQ Index, SP500, Dow Jones Forecasts – NASDAQ Rallies As CoreWeave Soars 24%
Dow Jones 111126 4h ChartDow Jones is moving higher amid broad rally in the equity markets. NVIDIA, which is up by +3.8%, is the biggest gainer in the Dow Jones index today. The stock has started to recover from the sell-off, which was triggered by the spy scandal. It remains to be seen whether this…
-
S&P 500 Sits 2.5% From a Record High Despite the Stock Market Crash
Photo by BeInCrypto Despite a historic stock market crash last week, the S&P 500 has largely recovered, and it’s now just 2.5% away from a new all-time high. Throughout 2026, Bitcoin has moved along with the stock market, driven by similar macroeconomic trends. However, the crypto market downturn is largely unmoved, so far. How the…
-
Stock Market Today, Nov. 11: Nvidia Rebounds as CoreWeave Earnings Reignite the AI Trade
Nvidia (NVDA +2.87%), the leading manufacturer of artificial intelligence (AI) chips and data center computing systems, rebounded 2.87% on Wednesday, November 11, closing at $173.73 as strong earnings from CoreWeave (CRWV +24.71%) helped restore confidence in the AI trade. The rally followed Tuesday’s steep sell-off, with investors finding renewed optimism in CoreWeave’s surging revenue and…
-
Stock Market Today, Nov. 11: CoreWeave Surges 25% on Beat-and-Raise Quarter
CRWV – CoreWeave $60.77+$12.04 (+24.71%) NASDAQ · As of 4:00 PM ET 11/11/26 CoreWeave (CRWV +24.71%), a specialized cloud infrastructure provider, closed at $60.77, up 24.71%. Quarterly results showed revenue of $3.66 billion and a raised 2026 outlook, easing financing and AI-demand worries. Investors are next watching revenue growth, profit outlook, and data center build…
-
A Fed Governor Called the Latest Inflation Data ‘Borderline Disturbing.’ A Half-Point Hike is Now Firmly on the Table.
Another Federal Reserve chair is raising alarms about the inflation trend, particularly following the October report, which surprised to the upside. Chicago Federal Reserve President Austan Goolsbee told PBS that the data was “borderline disturbing.” “We’ve got a real inflation issue on our hands that has been developing,” Goolsbee added. “We’re going to have to…
-
Can Lowe's Stock Keep Surging From Here?
Image from Pixabay For questions about this article or underlying research, email help@trefis.com. Lowe’s Companies (LOW) stock climbed 25.7% in the month to November 10, 2026, while the S&P 500 lost 3.6%. Anyone tempted to buy now may worry about paying for a move that has already happened. Management did give one firm signal in…
-
BioNTech vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?
Investors choosing between BioNTech (NASDAQ:BNTX) and Vertex Pharmaceuticals (NASDAQ:VRTX) must weigh the massive potential of mRNA cancer research against the reliable, high-margin cash flows of a dominant cystic fibrosis treatment leader. BioNTech is famous for its role in COVID-19 vaccines but is now pivoting toward oncology. Vertex Pharmaceuticals dominates the cystic fibrosis market while expanding…